Rhythm Pharmaceuticals Inc (NASDAQ:RYTM)

21.78
Delayed Data
As of Aug 12
 +1.84 / +9.23%
Today’s Change
3.04
Today|||52-Week Range
24.44
+118.24%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Rhythm Pharmaceuticals Inc have a median target of 26.50, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +21.67% increase from the last price of 21.78.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Rhythm Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.00
Sales
$5.7M
Reporting Date
Nov 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.22%
 
 
 
 
 
 
Growthannually -174.73%
 
 
 
 
 
 

Sales

Growthquarterly -36.84%
 
 
 
 
 
 
Growthannually 723.43%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.